In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
As of close of business last night, Sangamo Therapeutics Inc’s stock clocked out at $0.99, up 0.33% from its previous closing price of $0.99. In other words, the price has increased by $0.33 from its previous closing price. On the day, 3.24 million shares were traded.
Ratios:
To gain a deeper understanding of SGMO’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.35 and its Current Ratio is at 1.35. In the meantime, Its Debt-to-Equity ratio is 0.71 whereas as Long-Term Debt/Eq ratio is at 0.71.
On December 10, 2024, H.C. Wainwright reiterated its Buy ratingand also kept the price unchanged to $10.
RBC Capital Mkts Downgraded its Outperform to Sector Perform on November 03, 2023, whereas the target price for the stock was revised from $6 to $2.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 3.96 while its Price-to-Book (P/B) ratio in mrq is 5.29.
Stock Price History:
Over the past 52 weeks, SGMO has reached a high of $3.18, while it has fallen to a 52-week low of $0.30. The 50-Day Moving Average of the stock is -17.12%, while the 200-Day Moving Average is calculated to be -13.33%.
Shares Statistics:
A total of 208.62M shares are outstanding, with a floating share count of 199.25M. Insiders hold about 4.50% of the company’s shares, while institutions hold 29.73% stake in the company.
